About Index Trending news
Analyze
Top 50 Pricing
Valeant Pharmaceuticals

Valeant Pharmaceuticals

Work at Valeant Pharmaceuticals? Add yourself to this profile

Valeant Pharmaceuticals

Valeant is a multi-national specialty pharmaceutical company that develops products that make a meaningful difference in patients' lives.

Elsewhere

Contributors to this profile

Alexa global traffic share

Employees

Unknown size

The Motley Fool

Better Buy: Valeant Pharmaceuticals International, Inc. vs. Allergan

The Motley Fool

Valeant's New CEO Bought Shares -- Should You Too?

The Motley Fool

Valeant Pharmaceuticals' Headaches Grow -- Add 2 More to the List

Stock markets Earnings
The Motley Fool

Why Biogen, LendingClub, and Valeant Pharmaceuticals Slumped Today

Stock markets Health
The Motley Fool

Valeant Pharmaceuticals' 2016 Outlook Blemished by Continued Dermatology Woes

The Motley Fool

Valeant's Earnings Don't Matter!

The Motley Fool

Why Valeant Pharmaceuticals Is Crashing Yet Again

The Motley Fool

Valeant Pharmaceuticals Intl. Inc., Logged a Double-Digit Decline in May -- Here's Why

The Motley Fool

What to Expect in Valeant Pharmaceuticals' Q1 Results

The Motley Fool

5 Reasons Why There's Virtually No Chance Valeant Pharmaceuticals Will Be Bought Out

The Motley Fool

Another Month, Another 3 Reasons to Avoid Valeant Pharmaceuticals

Stock markets
The Motley Fool

Billionaire Battleground: Valeant Pharmaceuticals Shares Are in Wall Street's Crosshairs

The Motley Fool

Valeant Pharmaceuticals: New Documents Shed Light on the Philidor Fiasco

The Motley Fool

9 Reasons Why the Worst May Not Be Over for Valeant Pharmaceuticals

The Motley Fool

Why Pandora Media, Southwestern Energy, and Valeant Pharmaceuticals Jumped Today

Stock markets
The Motley Fool

What's Behind Valeant Pharmaceuticals Soaring 10% Today?

The Motley Fool

Valeant Pharmaceuticals Intl. Inc. Jumped 27% in April, But It's Not Out of the Woods

Stock markets Strategy
The Motley Fool

Valeant Pharmaceuticals' Mea Culpa May Throw the Entire Industry Under the Bus

Stock markets Health
The Motley Fool

One Mutual Fund That Valeant Pharmaceuticals International Inc. Took Down With It

Stock markets
The Motley Fool

The Only Way to Fix Valeant Pharmaceuticals Will Probably Disappoint Investors

Stock markets